Alto Neuroscience (ANRO) Institutional Ownership → Trump’s arrest is phase one (From Porter & Company) (Ad) Free ANRO Stock Alerts $11.81 +0.04 (+0.34%) (As of 06/7/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Alto Neuroscience (NYSE:ANRO)Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$57.78MNumber ofInstitutional Sellers(last 12 months)0 Get ANRO Insider Trade Alerts Want to know when executives and insiders are buying or selling Alto Neuroscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ANRO Institutional Buying and Selling by Quarter Ad Porter & CompanyThe new masters of energyAccording to one source, this new grid could soon provide energy to “one billion people in the world who don’t have access to electricity right now.” And early investors could make a fortune.Click here to get all the details. Alto Neuroscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/17/2024 RA Capital Management L.P.1,385,491$21.27M0.3%N/A5.154% 5/17/2024 Artal Group S.A.350,000$5.37M0.1%N/A1.302% 5/17/2024 Zimmer Partners LP75,000$1.15M0.0%N/A0.279% 5/16/2024 AWM Investment Company Inc.299,147$4.59M0.6%N/A1.113% 5/15/2024 Price T Rowe Associates Inc. MD637,604$9.79M0.0%N/A2.372% 5/10/2024 Vanguard Group Inc.536,332$8.23M0.0%N/A1.995% 5/2/2024 Jennison Associates LLC458,599$7.04M0.0%N/A1.706% 4/30/2024 University of Texas Texas AM Investment Managment Co.22,175$340K0.1%N/A0.082% (Data available from 1/1/2016 forward) ANRO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ANRO shares? During the previous two years, the following institutional investors and hedge funds held shares of Alto Neuroscience shares: RA Capital Management L.P. ($21.27M), Price T Rowe Associates Inc. MD ($9.79M), Vanguard Group Inc. ($8.23M), Jennison Associates LLC ($7.04M), Artal Group S.A. ($5.37M), AWM Investment Company Inc. ($4.59M), and Zimmer Partners LP ($1.15M).Learn more on ANRO's institutional investors. Which institutional investors have been buying Alto Neuroscience stock? The following institutional investors have purchased Alto Neuroscience stock in the last 24 months: RA Capital Management L.P. ($1.39M), Price T Rowe Associates Inc. MD ($637.60K), Vanguard Group Inc. ($536.33K), Jennison Associates LLC ($458.60K), Artal Group S.A. ($350K), AWM Investment Company Inc. ($299.15K), and Zimmer Partners LP ($75K). How much institutional buying is happening at Alto Neuroscience? Institutional investors have bought a total of 3,764,348 shares in the last 24 months. This purchase volume represents approximately $57.78M in transactions. Related Companies: MannKind Institutional Ownership Calliditas Therapeutics AB (publ) Institutional Ownership Day One Biopharmaceuticals Institutional Ownership AbCellera Biologics Institutional Ownership Mirum Pharmaceuticals Institutional Ownership Prothena Institutional Ownership Collegium Pharmaceutical Institutional Ownership Enliven Therapeutics Institutional Ownership Cassava Sciences Institutional Ownership Arcturus Therapeutics Institutional Ownership This page (NYSE:ANRO) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.